| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
32,653,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile scPharmaceuticals is a pharmaceutical company. Co.'s primary product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infusor and is under development for treatment of congestion in patients with worsening heart failure who display reduced responsiveness to oral diuretics and do not require hospitalization.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
762,380 |
| Total Buy Value |
$0 |
$0 |
$0 |
$4,002,495 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
826,622 |
| Total Sell Value |
$0 |
$0 |
$0 |
$3,585,860 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
4 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shah Rajeev M. |
10% Owner |
– – • |
2020-02-14 |
4/A |
B |
$8.20 |
$2,230,343 |
I/I |
271,993 |
3,518,998 |
1.5 |
- |
|
| Tucker John H |
President and CEO |
• • – |
2019-12-13 |
4 |
B |
$5.24 |
$26,189 |
D/D |
5,000 |
5,000 |
2.81 |
- |
|
| Ra Capital Biotech Fund Lp |
10% Owner |
– – • |
2019-04-11 |
4 |
B |
$2.70 |
$1,052,627 |
I/I |
389,862 |
3,247,005 |
1.5 |
- |
|
| Nokes Rachael |
See RemarksOfficer |
• – – |
2019-02-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,850 |
|
- |
|
| Schaeffer Leonard D |
Director |
– • – |
2017-12-19 |
4 |
OE |
$1.66 |
$37,567 |
D/D |
22,631 |
57,449 |
|
- |
|
| Agger Mette Kirstine |
Director |
– • • |
2017-11-21 |
4/A |
B |
$14.00 |
$9,166,668 |
I/I |
654,762 |
3,183,986 |
2.25 |
- |
|
| Silverstein Jonathan |
Director |
– • – |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,576,532 |
2,576,532 |
|
- |
|
| Schaeffer Leonard D |
Director |
– • – |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
43,104 |
43,104 |
|
- |
|
| Schaeffer Leonard D |
Director |
– • – |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
34,818 |
34,818 |
|
- |
|
| Rocklage Scott M |
10% Owner |
– – • |
2017-11-21 |
4 |
B |
$14.00 |
$9,166,668 |
I/I |
654,762 |
130,135 |
1.5 |
- |
|
| Rocklage Scott M |
10% Owner |
– – • |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,598,675 |
103,945 |
|
- |
|
| Agger Mette Kirstine |
Director |
– • – |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,529,224 |
2,529,224 |
|
- |
|
| Lundbeckfond Invest A/s |
10% Owner |
– – • |
2017-11-21 |
4 |
B |
$14.00 |
$9,166,668 |
D/D |
654,762 |
3,183,986 |
2.45 |
- |
|
| Lundbeckfond Invest A/s |
10% Owner |
– – • |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,529,224 |
2,529,224 |
|
- |
|
| Coleman Dorothy |
Director |
– • – |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
14,348 |
14,348 |
|
- |
|
| Isaly Samuel D |
10% Owner |
– – • |
2017-11-21 |
4 |
B |
$14.00 |
$11,666,662 |
I/I |
833,333 |
3,409,865 |
1.5 |
- |
|
| Isaly Samuel D |
10% Owner |
– – • |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,576,532 |
2,576,532 |
|
- |
|
| Sun Pharmaceutical Industries, Inc. |
10% Owner |
– – • |
2017-11-21 |
4 |
B |
$14.00 |
$5,000,002 |
I/I |
357,143 |
357,143 |
1.5 |
- |
|
| Sun Pharmaceutical Industries, Inc. |
10% Owner |
– – • |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
1,810,536 |
1,810,536 |
|
- |
|
44 Records found
|
|
Page 2 of 2 |
|
|
